Literature DB >> 24894128

Flank muscle volume changes after open and laparoscopic partial nephrectomy.

Sebastien Crouzet1, Sameer Chopra, Sheaumei Tsai, Kazumi Kamoi, Georges-Pascal Haber, Erick M Remer, Andre K Berger, Inderbir S Gill, Monish Aron.   

Abstract

PURPOSE: To determine the occurrence of flank symptoms, flank muscle atrophy, bulge, and hernia formation after open and laparoscopic partial nephrectomy (LPN). PATIENTS AND METHODS: Our prospective Institutional Review Board-approved database was queried to identify 50 consecutive patients who were treated with open partial nephrectomy (OPN) and 50 consecutive patients who were treated with LPN between September 2006 and May 2008. Study patients had: Solitary clinical T1 renal tumor, preoperative and ≥6 month postoperative CT scan performed at our institution, and a confirmed renal-cell carcinoma on the final pathology report. Patients with previous abdominal surgery and neuromuscular disorders were excluded. Oncocare software was used to measure abdominal wall musculature on preoperative and postoperative CT scan. Bilateral flanks were compared for muscle volume, bulge, and hernia. Patients were administered a phone questionnaire to assess postoperative flank symptoms.
RESULTS: No statistical significant difference was found in the demographics between the two groups. Median age (range) was 59.9 years (20.6-80.7) in the OPN group and 57.5 years (25-78) in the LPN group (P=0.89). Median (range) body mass index and American Society of Anesthesiologists scores were similar between the two groups. On CT scans, median percent variation (range) in abdominal wall muscle volume was significantly greater in the OPN group: -1.03% (-31.4-1.5) vs-0.39% (-5.2-1.8) (P=0.006). The median extent of flank bulge on CT scans (range) was also greater in the OPN group: 0.75 cm (-1.9-7.6) vs 0 cm (-2.7-2.8) (P=0.0004). The OPN group was also more symptomatic, including paresthesia 48% vs 8% (P=0.0053); numbness 44% vs 0% (P=0.002); and flank bulge 57% vs 12% (P=0.007).
CONCLUSIONS: Minimally invasive partial nephrectomy has lesser deleterious impact on flank muscle volume compared with OPN with fewer symptoms of flank bulge, paresthesia, and numbness.

Entities:  

Mesh:

Year:  2014        PMID: 24894128     DOI: 10.1089/end.2013.0782

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  5 in total

1.  Assessing the effects of modality of surgery on postoperative weight loss in patients undergoing partial nephrectomy.

Authors:  Homayoun Zargar; Oktay Akca; Peter Caputo; Daniel Ramirez; Onder Kara; Hiury S Andrade; Robert J Stein; Jihad H Kaouk
Journal:  World J Urol       Date:  2016-06-07       Impact factor: 4.226

2.  Open retromuscular large mesh reconstruction of lumbar incisional hernias including the atrophic muscular area.

Authors:  Y Renard; L de Mestier; A Cagniet; N Demichel; C Marchand; J-L Meffert; R Kianmanesh; J-P Palot
Journal:  Hernia       Date:  2017-01-17       Impact factor: 4.739

3.  Reverse TAR may be added when necessary in open preperitoneal repair of lateral incisional hernias: a retrospective multicentric cohort study.

Authors:  Joaquin M Munoz-Rodriguez; Javier Lopez-Monclus; Marina Perez-Flecha; Alvaro Robin-Valle de Lersundi; Luis A Blazquez-Hernando; Ana Royuela-Vicente; Juan P Garcia-Hernandez; Aritz Equisoain-Azcona; Manuel Medina-Pedrique; Miguel A Garcia-Urena
Journal:  Surg Endosc       Date:  2022-06-28       Impact factor: 4.584

Review 4.  Incidence, etiology, management, and outcomes of flank hernia: review of published data.

Authors:  D J Zhou; M A Carlson
Journal:  Hernia       Date:  2018-01-27       Impact factor: 4.739

5.  Demographic characteristics and complications of open and minimally invasive surgeries for renal cell carcinoma: a population-based case-control study in Taiwan.

Authors:  Ying-Hsu Chang; Su-Wei Chang; Chung-Yi Liu; Po-Hung Lin; Kai-Jie Yu; See-Tong Pang; Cheng-Keng Chuang; Hung-Cheng Kan; I-Hung Shao
Journal:  Ther Clin Risk Manag       Date:  2018-07-13       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.